Golimumab is used in the treatment of ulcerative colitis, Crohn’s disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis.
Golimumab works by blocking the action of specific chemical messengers that are responsible for inflammation, swelling, and redness associated with certain joint diseases.
Common side effects of Golimumab include upper respiratory tract infection and nasopharyngitis, which is the inflammation of the throat and nasal passages.